Where the group operates
By market
Line mix
Premium over time
Group premium
What drove the growth
Profit and return on equity
Net profit by year
Companies that report profit
Solvency of the companies
Combined ratio against the market
company its market 100%
Against the largest groups
Listed shares
MetLife shares trade on the New York Stock Exchange as MET. Share price and market value at each year end, as MetLife publishes them; a dash where it does not. No live price: exchanges license their data. Investor relations →
| Year | Share price | Market value |
|---|---|---|
| 2025 | USD 78.94 | USD 52.0bn |
| 2024 | USD 81.88 | USD 56.4bn |
| 2023 | USD 66.13 | USD 48.9bn |
| 2022 | USD 72.37 | — |
| 2021 | USD 62.49 | — |
Sources: MetLife Form 10-K 2022, equity note (share price 2021–2022); MetLife Form 10-K 2023, equity note (share price 2023); MetLife Form 10-K 2025, equity note (share price 2024–2025); MetLife proxy statement 2024 (market value 2023); MetLife proxy statement 2025 (market value 2024); MetLife proxy statement 2026 (market value 2025).
Companies
Each company in its own market. Solvency is the SCR ratio; * outside Solvency II (Serbia, Montenegro, Bosnia and Herzegovina, North Macedonia, Albania, Kosovo* and Moldova): local solvency margin; their combined ratios come from the insurers' whole-company figures (approximate loss ratio where expenses are not published) and are not comparable with the Solvency II markets. With a line selected, premium, share, rank and growth are the company's in that line; solvency, combined ratio, net profit and life share stay the whole company's. The combined ratio is after reinsurance (≈ an estimate; marked gross where a company publishes none); net profit after tax is from each company's own accounts.
| Company | Market | Premium | Share in market | Rank |
|---|---|---|---|---|
| MetLife (branch) | Hungary | 138.4 | 2.7% | #11 of 25 |
| MetLife Europe (branch) | Czechia | 132.1 | 1.6% | #11 of 22 |
| MetLife Europe (branch) | Slovakia | 124.0 | 3.9% | #7 of 13 |